Register Now: Reshoring Maufacturing and Securing Cold-Chain Supply For Biopharma

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Mercedes Segura Gally

Mercedes Segura Gally is vice-president of Vector Process Development at ElevateBio.

Articles by Mercedes Segura Gally

David Crockett/Stock.Adobe.com – Rapid growth in cell-based immuno-oncology pipelines and early development efforts with in-vivo lentiviral vector-based therapies are fueling CGT growth.

Tactics and Strategies for Designing an Ideal Lentiviral Vector Platform

ByBojiao Yin,Mercedes Segura Gally,Jimmy Xin,James Fasano

March 1st 2023

There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.

Latest Updated Articles